当前位置:首页 - 行情中心 - 艾德生物(300685) - 财务分析 - 现金流量表

艾德生物

(300685)

  

流通市值:90.74亿  总市值:91.19亿
流通股本:3.90亿   总股本:3.92亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金870,428,221.69556,638,451.47284,254,114.961,118,334,930.68
  收到其他与经营活动有关的现金45,712,713.6120,496,468.246,605,025.4553,556,019.93
  经营活动现金流入小计916,140,935.3577,134,919.71290,859,140.411,171,890,950.61
  购买商品、接受劳务支付的现金108,066,812.4166,363,975.1331,374,465.02154,659,760.55
  支付给职工以及为职工支付的现金255,460,199.33167,322,050.5492,870,145.07311,936,843.36
  支付的各项税费116,092,977.1572,534,139.6121,884,962.0883,867,656.11
  支付其他与经营活动有关的现金161,134,352.94100,331,471.2841,474,715.4279,581,092.51
  经营活动现金流出小计640,754,341.83406,551,636.56187,604,287.57830,045,352.53
  经营活动产生的现金流量净额275,386,593.47170,583,283.15103,254,852.84341,845,598.08
二、投资活动产生的现金流量:
  收回投资收到的现金259,409,989.45200,000,000-580,259,597.92
  取得投资收益收到的现金9,461,421.063,395,060.45-14,294,638
  处置固定资产、无形资产和其他长期资产收回的现金净额---215,728.17
  投资活动现金流入的平衡项目00-0
  投资活动现金流入小计268,871,410.51203,395,060.45-594,769,964.09
  购建固定资产、无形资产和其他长期资产支付的现金55,714,823.7830,374,747.2511,256,559.440,207,733.58
  投资支付的现金337,837,164.51204,255,623.45103,454,181.14627,861,577.78
  投资活动现金流出小计393,551,988.29234,630,370.7114,710,740.54668,069,311.36
  投资活动产生的现金流量净额-124,680,577.78-31,235,310.25-114,710,740.54-73,299,347.27
三、筹资活动产生的现金流量:
  取得借款收到的现金90,000,00065,000,000--
  收到其他与筹资活动有关的现金153,559.36129,357.98-249,405
  筹资活动现金流入平衡项目00-0
  筹资活动现金流入小计90,153,559.3665,129,357.98-249,405
  偿还债务支付的现金45,100,00044,400,000-7,240,000
  分配股利、利润或偿付利息支付的现金117,368,747.7193,089,811.38444,00060,592,428.94
  支付其他与筹资活动有关的现金36,689,965.9935,237,654.1317,234,780.4992,057,336.08
  筹资活动现金流出小计199,158,713.7172,727,465.5117,678,780.49159,889,765.02
  筹资活动产生的现金流量净额-109,005,154.34-107,598,107.53-17,678,780.49-159,640,360.02
四、汇率变动对现金及现金等价物的影响3,602,104.049,345,925.352,606,466.465,478,078.36
五、现金及现金等价物净增加额45,302,965.3941,095,790.72-26,528,201.73114,383,969.15
  加:期初现金及现金等价物余额315,461,835.82315,461,835.82315,461,835.82201,077,866.67
  期末现金及现金等价物余额360,764,801.21356,557,626.54288,933,634.09315,461,835.82
补充资料:
  净利润-189,037,382.96-254,863,444.95
  资产减值准备-5,486,930.76-38,368,955.4
  固定资产和投资性房地产折旧-23,507,867.14-44,682,018.11
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-23,507,867.14-44,682,018.11
  无形资产摊销-3,701,408.44-7,370,642.61
  长期待摊费用摊销-2,026,801.97-3,234,891.03
  处置固定资产、无形资产和其他长期资产的损失-1,759,674.77-1,063,253.41
  固定资产报废损失--43,497.08-62,049.88
  公允价值变动损失--3,241,563.21--8,768,533.37
  财务费用--10,255,253.35-1,906,947.65
  投资损失--222,855.74-9,254,440.03
  递延所得税--1,190,183.27--4,811,405.67
  其中:递延所得税资产减少--1,190,183.27--4,811,405.67
  存货的减少--7,552,217.17--5,582,833.17
  经营性应收项目的减少--86,691,916.35--38,356,182.04
  经营性应付项目的增加-52,162,857.41-34,734,992.29
  现金的期末余额-356,557,626.54-315,461,835.82
  减:现金的期初余额-315,461,835.82-201,077,866.67
  现金及现金等价物的净增加额-41,095,790.72-114,383,969.15
公告日期2025-10-252025-07-292025-04-222025-04-22
审计意见(境内)标准无保留意见
TOP↑